Back
ImmunoPrecise Antibodies Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
13
IPA
ImmunoPrecise Antibodies
Last Price:
0.34
Seasonality Move:
4.89%
Buy
68
AUPH
Aurinia Pharmaceuticals
Last Price:
9.00
Seasonality Move:
24.51%
Sell
13
ImmunoPrecise Antibodies (IPA)
is a Sell
Is ImmunoPrecise Antibodies a Buy, Sell or Hold?
- The current ImmunoPrecise Antibodies [IPA] share price is $0.35. The Score for IPA is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- IPA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
68
Aurinia Pharmaceuticals (AUPH)
is a Buy
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $8.77. The Score for AUPH is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- AUPH is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IPA Stock Price Chart
What is ImmunoPrecise Antibodies's stock price today?
-
The ImmunoPrecise Antibodies share price today is $0.35
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPA is experiencing slight selling pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $8.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 30.91 | Sell |
| Chaikin Money Flow: | -183904 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.4 - 0.54) | Sell |
| Bollinger Bands (100): | (0.51 - 0.87) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 71.82 | Buy |
| Chaikin Money Flow: | 1867716 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.13 - 8.27) | Buy |
| Bollinger Bands (100): | (5.79 - 7.57) | Buy |
IPA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.43 | Sell |
| 20-day SMA: | 0.46 | Sell |
| 50-day SMA: | 0.55 | Sell |
| 200-day SMA: | 1.04 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.45 | Sell |
| 50-day EMA: | 0.54 | Sell |
| 200-day EMA: | 1.01 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.28 | Buy |
| 20-day SMA: | 7.86 | Buy |
| 50-day SMA: | 7.38 | Buy |
| 200-day SMA: | 6.09 | Buy |
| 8-day EMA: | 8.28 | Buy |
| 20-day EMA: | 7.95 | Buy |
| 50-day EMA: | 7.43 | Buy |
| 200-day EMA: | 6.82 | Buy |
ImmunoPrecise Antibodies Earnings Growth & IPA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.09 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.54 per share.
ImmunoPrecise Antibodies Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||